Examination of the topical effect of the combination of Plantago ovata and vinegar on the improvement of rural cutaneous leishmaniasis lesions


1 Department of Dermatology, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 Department of Persian Medicine, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

3 Department of Biostatistics and Epidemiology, School of Health, Social Determents of Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Department of Persian Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran


Background: The present study aimed at investigating the topical effect of the combination of Plantago ovata and vinegar on the improvement of rural cutaneous leishmaniasis lesions.
Materials and Methods: The present randomized double-blind controlled clinical trial was performed on 42 patients with rural skin leishmaniasis. In the case group, in addition to injecting glucantime into the lesion according to the latest national instructions, a combination of P. ovata and vinegar was applied topically twice a day for 8 weeks. In the control group, only glucantime injection into the lesion was performed for 8 weeks according to the latest national guidelines. At the end of the 1st, 2nd, 3rd, 4th, 8th, and 12th weeks after the intervention, the lesion area and improvement were evaluated and recorded.
Results: The results of the present study indicated the lesion area in the case group with the mean of 0.35 ± 0.39 cm and 0.18 ± 0.27 cm in the 8th and 12th weeks, respectively was significantly less than that of the control group with the mean of 0.64 ± 0.78 cm and 0.56 ± 0.44, respectively (P < 0.05). Twelve weeks after the intervention, 84.1% of the lesions in the case group and 65.9% of the lesions in the control group were completely improved (P < 0.05).
Conclusion: According to the results of the present study, the improvement of leishmaniasis lesion with the topical application of the combination of P. ovata and vinegar was significantly more than that of the control group in the 8th and 12th weeks after the intervention.


John DT, Petri WA. Markell & Voge's Medical Parasitology. 10th Sea ed. Singapore: Elsevier Pte Limited; 2020.  Back to cited text no. 1
Jorjani O, Mirkarimi K, Charkazi A, Shahamat YD, Mehrbakhsh Z, Bagheri A. The epidemiology of cutaneous leishmaniasis in Golestan Province, Iran: A cross-sectional study of 8-years. Parasite Epidemiol Control 2019;5:e00099.  Back to cited text no. 2
Alemayehu B, Alemayehu M. Leishmaniasis: A review on parasite, vector and reservoir host. Health Sci J 2017;11:1.  Back to cited text no. 3
Aronson NE, Joya CA. Cutaneous leishmaniasis: Updates in diagnosis and management. Infect Dis Clin North Am 2019;33:101-17.  Back to cited text no. 4
Jaffary F, Nilforoushzadeh MA, Ansari N, Rahimi M. Treatment of cutaneous leishmaniasis: Cassia fistula fruit gelintralesionalglucantime vs. placebo gel – Intralesionalglucantime combination. Tehran Univ Med J 2010;67:705-11.  Back to cited text no. 5
Piroozi B, Moradi G, Alinia C, Mohamadi P, Gouya MM, Nabavi M, et al. Incidence, burden, and trend of cutaneous leishmaniasis over four decades in Iran. Iran J Public Health 2019;48 Suppl 1:28-35.  Back to cited text no. 6
Blum J, Desjeux P, Schwartz E, Beck B, Hatz C. Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 2004;53:158-66.  Back to cited text no. 7
Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007;7:581-96.  Back to cited text no. 8
Firooz A, Khatami A, Khamesipour A, Nassiri-Kashani M, Behnia F, Nilforoushzadeh M, et al. Intralesional injection of 2% zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: A randomized, double-blind, controlled clinical trial. J Drugs Dermatol 2005;4:73-9.  Back to cited text no. 9
Farajzadeh S, Heshmatkhah A, Vares B, Mohebbi E, Mohebbi A, Aflatoonian M, et al. Topical terbinafine in the treatment of cutaneous leishmaniasis: Triple blind randomized clinical trial. J Parasit Dis 2016;40:1159-64.  Back to cited text no. 10
Vecchiato NL. Traditional medicine. In: The Ecology of Health and Disease in Ethiopia. Philadelphia: Routledge; 2019: 157-78.  Back to cited text no. 11
Parvizi MM, Zare F, Handjani F, Nimrouzi M, Zarshenas MM. Overview of herbal and traditional remedies in the treatment of cutaneous leishmaniasis based on traditional Persian medicine. Dermatol Ther 2020;33:e13566.  Back to cited text no. 12
Nazem Jahan M. Exir-e Azam. Tehran (Iran): Medicine Science University of Iran. 2008. p. 452.  Back to cited text no. 13
Rahmani, Arshad H. Cassia fistula Linn: Potential candidate in the health management. Pharmacognosy research, 2015;7:217.  Back to cited text no. 14
Asmar M, Farahmand BM, Aghighi Z, Ghaemi N, Ayat EA. In vitro and in vivo evaluation of therapeutic effects of vinca major alkaloids on leishmania major. Journal of school of public health and institute of public health research; 2002;1:1-8.  Back to cited text no. 15
Hejazi SH, Shirani-Bidabadi L, Zolfaghari-Baghbaderani A, Saberi SE, Nilforoushzadeh MA, Moradi SH, et al. Comparison effectiveness of extracts of thyme, yarrow, henna and garlic on cutaneous leishmaniasis caused by L. major in animal model (Balb/c). J Med Plants 2009;8:129-60.  Back to cited text no. 16
Mozafari O, Yousef Pour M, Mozafari A, Soufizadeh A, Yousefi SS. Cutaneous leishmaniasis from the perspective of traditional Iranian medicine. J Mazandaran Univ Med Sci 2016;26:277-84.  Back to cited text no. 17
Moshfe A, Bahmani M, Naghmachi M, Askarian SH, Rezaei A, Zare RH. Antileishmanial effect of plantago psyllium and white vinegar on Leishmania major lesion in balb/c mice. In: National Symposium and 1st International Congress of Parasitology and Parasitic Diseases in Iran. Shiraz; 2012. p. 136-7.  Back to cited text no. 18
Saghafipour A, Mozaffari E, Rezaei F. The evaluation of intralesional glucantime and cryotherapy plus intralesional glucantime therapeutic efficacy on zoonotic cutaneous leishmaniasis: A randomized clinical trial. Int J Pediatr 2017;5:6689-97.  Back to cited text no. 19
Ghazanfari T, Shahrokhi S, Naseri M, Jalali Nadoushan MR, Yaraie R, Kardar M. The cytotoxic effects a of ACA1 on human melanoma cell line. J Mazandaran Univ Med Sci 2006;16:42-9.  Back to cited text no. 20
Borda LJ, Macquhae FE, Kirsner RS. Wound dressings: A comprehensive review. Curr Dermatol Rep 2016;5:287-97.  Back to cited text no. 21
Elhage KG, St. Claire K, Daveluy S. Acetic acid and the skin: A review of vinegar in dermatology. Int J Dermatol 2021;60:1-8.  Back to cited text no. 22
Basiri S, Shekarforoush SS, Mazkour S, Modabber P, Kordshouli FZ. Evaluating the potential of mucilaginous seed of psyllium (Plantago ovata) as a new lead biosorbent. Bioact Carbohydr Diet Fibre 2020;24:100242.  Back to cited text no. 23
Sarfraz RM, Khan H, Maheen S, Afzal S, Akram MR, Mahmood A, et al. Plantago ovata: A comprehensive review on cultivation, biochemical, pharmaceutical and pharmacological aspects. Acta Pol Pharm 2017;74:739-46.  Back to cited text no. 24
Haddadian K, Haddadian K, Zahmatkash M. A Review of Plantago Plant. Indian Journal of Traditional Knowledge, 2014; 13: 681-685.  Back to cited text no. 25
Reddy PR, Vandana KV, Prakash S. Antibacterial and anti-inflammatory properties of Plantago ovata Forssk. leaves and seeds against periodontal pathogens: An in vitro study. Ayu 2018;39:226-9.  Back to cited text no. 26
[PUBMED]  [Full text]  
Dermarderosian A. The Review of Natural Productions. Facts and Comparison. Vol. 13. United States: Wolters Kluwer Company USA; 2001. p. 473-6.  Back to cited text no. 27
Parvizi MM, Handjani F, Moein M, Hatam G, Nimrouzi M, Hassanzadeh J, et al. Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of old world cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial. PLoS Negl Trop Dis 2017;11:e0005957.  Back to cited text no. 28
Nilforoushzadeh MA, Jaffary F, Moradi S, Derakhshan R, Haftbaradaran E. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis. BMC Complement Altern Med 2007;7:13.  Back to cited text no. 29
Hamdan II, Afifi FU. Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. J Ethnopharmacol 2004;93:117-21.  Back to cited text no. 30
Marongiu B, Piras A, Porcedda S, Scorciapino A. Chemical composition of the essential oil and supercritical CO2 extract of Commiphora myrrha (Nees) Engl. and of Acorus calamus L. J Agric Food Chem 2005;53:7939-43.  Back to cited text no. 31
Morteza-Semnani K, Saeedi M. Constituents of the essential oil of Commiphora myrrha (Nees) Engl. var. molmol. J Essent Oil Res 2003;15:50-1.  Back to cited text no. 32
Das I, Chakrabarty RN, Das S. Saffron can prevent chemically induced skin carcinogenesis in Swiss albino mice. Asian Pac J Cancer Prev 2004;5:70-6.  Back to cited text no. 33
Lee HJ, Hyun EA, Yoon WJ, Kim BH, Rhee MH, Kang HK, et al. In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. J Ethnopharmacol 2006;103:208-16.  Back to cited text no. 34
Nejad AS, Bahmani M, Shah NA, Shah SA, Rafieian-Kopaei M. Beliefs of herbal therapies of the community of the Ilam city of Ilam province, Iran. J Pharm Pharmacogn Res 2018;6:299-317.  Back to cited text no. 35
da Silva ET, de Andrade GF, Araújo AD, Almeida AD, Coimbra ES, de Souza MV. In vitro assessment of camphor hydrazone derivatives as an agent against Leishmania amazonensis. Acta Parasitol 2020;65:203-7.  Back to cited text no. 36
Nilforoushzadeh MA, Hejazi SH, Zarkoob H, Shirani-Bidabadi L, Jaffary F. Efficacy of adding topical honey-based hydroalcoholic extract Nigella sativa 60% compared to honey alone in patients with cutaneous leishmaniasis receiving intralesional glucantime. J Skin Leishmaniasis 2010;1:1-7.  Back to cited text no. 37
Chevrier MR, Ryan AE, Lee DY, Zhongze M, Wu-Yan Z, Via CS. Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol 2005;12:575-80.  Back to cited text no. 38